Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa; Idelvion

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

1. Molecular engineering approaches to half-life extension of therapeutic biomolecules.Frontiers in pharmacology · 2026
   Review
2. Transformative approaches in hemophilia management: from traditional therapies to prenatal stem cell treatment.Frontiers in bioengineering and biotechnology · 2025
   Review
3. Intracranial hemorrhage in an infant leads to the diagnosis and treatment of severe hemophilia B: a case report.Italian journal of pediatrics · 2024
   Article
4. Therapeutic Fusion Proteins.The AAPS journal · 2023
   Review
5. Perioperative management of a patient with haemophilia B and PSVT undergoing radiofrequency ablation: A case report.The Journal of international medical research · 2023
   Article
6. Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design.Biomedicines · 2023
   Review
7. [Advances in long-acting recombinant factor Ⅸ for the treatment of hemophilia B].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
   Article
8. A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives.Acta pharmaceutica Sinica. B · 2021
   Review
9. Current therapeutic approaches in the management of hemophilia-a consensus view by the Romanian Society of Hematology.Annals of translational medicine · 2021
   Review
10. Identification of novel glycosylation events on human serum-derived factor IX.Glycoconjugate journal · 2020
    Article
11. Albumin-neprilysin fusion protein: understanding stability using small angle X-ray scattering and molecular dynamic simulations.Scientific reports · 2020
    Article
12. Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples.International journal of laboratory hematology · 2020
    Article
13. Discovery of An Orally Effective Factor IX-Transferrin Fusion Protein for Hemophilia B.International journal of molecular sciences · 2019
    Article
14. Locally anchoring enzymes to tissues via extracellular glycan recognition.Nature communications · 2018
    Article
15. Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B.Therapeutic advances in hematology · 2018
    Review
16. Battle of GLP-1 delivery technologies.Advanced drug delivery reviews · 2018
    Review
17. Nonacog Beta Pegol: A Review in Haemophilia B.Drugs · 2017
    Review
18. Optimizing Perioperative Management of Haemophilia B With rFIX-FP: Pharmacokinetic Validation of the Hemoptidose Tool.Haemophilia : the official journal of the World Federation of Hemophilia
    Article
19. Safety, Efficacy and Treatment Patterns of rIX-FP in Previously Untreated Paediatric Haemophilia B Patients: A Retrospective Chart Review in Japan.Haemophilia : the official journal of the World Federation of Hemophilia
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as